The following tools and resources on special topics in psoriasis have been compiled to assist you in managing psoriasis in clinical practice.
IPC’s International Fellowship program provides young dermatologists and researchers interested in psoriasis full access to the knowledge of our network of experts and represents our commitment to cultivating expertise in the field.
The IPC Psoriasis Masterclass program is designed for early to mid-career dermatologists interested in improving their expertise in caring for psoriasis patients. The program is a robust 10-hour curriculum delivered by international and regional experts.
This CME-accredited activity is for US dermatology and primary care professionals who treat psoriasis, aiming to improve evidence-based use of systemic and biologic therapies aligned with current guidelines.
This course from the World Health Organization (WHO) Academy provides an overview of psoriasis epidemiology, clinical features and subtypes, diagnosis, and management, along with perspectives on living with the disease.
How familiar are you with the latest in psoriasis care? Take these quizzes to find out.
IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.
IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.
Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.
Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.
